Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity

BACKGROUND: As a non-invasive and effective diagnostic method for small intestinal bacterial overgrowth (SIBO), wild-use of breath test (BT) has demonstrated a high comorbidity rate in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) and SIBO. Patients overlapping with SIBO respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zuojing, Zhu, Shiwei, He, Meibo, Li, Mo, Wei, Hui, Zhang, Lu, Sun, Qinghua, Jia, Qiong, Hu, Nan, Fang, Yuan, Song, Lijin, Zhou, Chen, Tao, Heqing, Kao, John Y, Zhu, Huaiqiu, Owyang, Chung, Duan, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509105/
https://www.ncbi.nlm.nih.gov/pubmed/36070467
http://dx.doi.org/10.1097/CM9.0000000000002294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509105/
https://www.ncbi.nlm.nih.gov/pubmed/36070467
http://dx.doi.org/10.1097/CM9.0000000000002294

Ejemplares similares